HXBM (Helix Biomedix) Total Receivables: $0.40 Mil (As of Sep. 2012)


What is Helix Biomedix Total Receivables?

Helix Biomedix HXBM Total Receivables is $0.40 Mil as of Sep. 2012.

Helix Biomedix's Total Receivables for the quarter that ended in Sep. 2012 was $0.40 Mil.

Helix Biomedix Total Receivables Related Terms

Helix Biomedix Total Receivables Historical Data

* Premium members only.

The historical data trend for Helix Biomedix's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix Biomedix Total Receivables Chart

Helix Biomedix Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.05 0.06 0.29 0.44

Helix Biomedix Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.44 0.66 0.34 0.40

Helix Biomedix Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.40 Mil mean?
Helix Biomedix (HXBM) has a Total Receivables of $0.40 Mil as of Sep. 2012. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Helix Biomedix and its competitors.
Is Helix Biomedix's Total Receivables too high?
Helix Biomedix's current Total Receivables is $0.40 Mil.
How does Helix Biomedix's Total Receivables compare to XBIO and CBLI?
Helix Biomedix's Total Receivables of $0.40 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Helix Biomedix and its competitors. Helix Biomedix's current Total Receivables is $0.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helix Biomedix stock overvalued right now?
Helix Biomedix (HXBM) has a current Total Receivables of $0.40 Mil. The current Total Receivables is $0.40 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Helix Biomedix (HXBM), the current Total Receivables is $0.40 Mil as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helix Biomedix Business Description

Address 19125 North Creek Parkway, Suite 120, Bothell, WA, USA, 98011
Helix Biomedix Inc is a Delaware-based biopharmaceutical company that focuses on the early-stage development of peptide-based therapeutics for dermatology and skin health. The Company is in the preclinical stage, advancing a rare disease drug program for xeroderma pigmentosum, and plans to seek orphan drug designation before entering clinical development. Leveraging its proprietary peptide technology, Helix BioMedix aims to address unmet needs in rare dermatological conditions and has a history of developing patented bioactive peptides for topical personal care use.